Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis
- 29 July 2010
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 116 (4) , 649-652
Abstract
Although allogeneic hematopoietic stem cell transplantation has recently been applied to patients with myelofibrosis with reproducible engraftment and resolution of marrow fibrosis, no data describe the outcomes of umbilical cord blood transplantation. We describe 14 patients with primary (n = 1) and secondary myelofibrosis (n = 13) who underwent reduced-intensity umbilical cord blood transplantation. Conditioning regimens included fludarabine and graft-versus-host disease prophylaxis composed cyclosporine/tacrolimus alone (n = 6) or a combination of tacrolimus and mycophenolate mofetil (n = 8). Thirteen patients achieved neutrophil engraftment at a median of 23 days. The cumulative incidence of neutrophil and platelet engraftment was 92.9% at day 60 and 42.9% at day 100, respectively. Posttransplantation chimerism analysis showed full donor type in all patients at a median of 14 days. The use of umbilical cord blood could be feasible even for patients with severe marrow fibrosis, from the viewpoint of donor cell engraftment.Keywords
This publication has 21 references indexed in Scilit:
- High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adultsBritish Journal of Haematology, 2009
- Allogeneic hematopoietic cell transplantation for patients with myelofibrosisCurrent Opinion in Hematology, 2009
- Allogeneic hematopoietic stem cell transplantation for myelofibrosisHaematologica, 2008
- Allogeneic Hematopoietic Cell Transplantation following Reduced Intensity Conditioning for Treatment of MyelofibrosisTransplantation and Cellular Therapy, 2006
- Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced‐intensity conditioning regimensBritish Journal of Haematology, 2006
- Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasiaBlood, 2005
- Allogeneic hematopoietic stem cell transplantation for myelofibrosisBlood, 2003
- Stem cell transplantation for myelofibrosis: a report from two Canadian centersBone Marrow Transplantation, 2003
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958